CD163 is also involved in regulating the role of CK2 in glioma stemness by interacting with CK2β, leading to an increase in phosphorylation of AKT, GSK-3β/β-catenin pathway activity, inappropriate cell cycle progression, and glioma proliferation [68]. This evidence concerns the gene AKT1 and central nervous system cancer.